Cytomel (Liothyronine) Cost in Mississippi 2026

What Does Liothyronine Actually Cost in Mississippi Right Now?

Generic liothyronine tablets run about $35 per month at Mississippi retail pharmacies when paying without insurance in 2026. Brand-name Cytomel carries a manufacturer list price near $120 per month, but that figure rarely reflects what a cash-paying patient in Jackson, Gulfport, or Hattiesburg actually pays at the counter. Discount programs routinely reduce the generic to under $15 at chains like Walmart, Kroger Pharmacy, and CVS.

Liothyronine is the synthetic form of triiodothyronine (T3), the more metabolically active thyroid hormone. The FDA approved Cytomel for hypothyroidism, pituitary TSH suppression, and thyroid diagnostic testing. The current FDA prescribing information for Cytomel is available at accessdata.fda.gov. Levothyroxine (T4) remains the first-line standard of care per American Thyroid Association guidelines, but some patients do not adequately convert T4 to T3, creating genuine clinical need for liothyronine supplementation. [1]

The 1999 NEJM trial by Bunevicius et al. (N=33) found that a combination of thyroxine plus triiodothyronine improved mood, neuropsychological function, and physical status compared with thyroxine alone in patients with hypothyroidism, establishing a clinical rationale for T3 prescribing that continues to drive demand. [2] Separate research published in Thyroid (2019) confirmed that roughly 5 to 10 percent of hypothyroid patients on levothyroxine monotherapy report persistent symptoms despite normal TSH, making T3 adjuncts a practical consideration for a meaningful subset of Mississippians on thyroid therapy. [3]

Price variation across Mississippi ZIP codes can be meaningful. Rural counties in the Delta may have fewer competing pharmacies, so calling ahead or using a GoodRx-type comparison tool before driving to a pharmacy remains worthwhile. Walmart's $4/$10 generic program has historically included select thyroid medications, though liothyronine availability on that list varies by store and must be confirmed locally.

Does Mississippi Medicaid Cover Liothyronine?

Mississippi Medicaid does not cover Cytomel or generic liothyronine as of 2026. The Mississippi Division of Medicaid's preferred drug list (PDL) includes levothyroxine as the covered first-line thyroid hormone replacement, but liothyronine is excluded. Patients enrolled in Mississippi Medicaid who need T3 therapy face full out-of-pocket costs unless they obtain a documented medical exception.

Requesting a prior authorization (PA) for a non-covered drug on Mississippi Medicaid is possible but uncommon for liothyronine. A physician would need to document clinical failure of levothyroxine monotherapy, an inability to adequately convert T4 to T3 (confirmed by persistently low free T3 with normal TSH), or another medically necessary indication. The Mississippi Division of Medicaid publishes its PA criteria at medicaid.ms.gov. Approval rates for liothyronine PAs are not publicly reported, so individual outcomes vary.

Patients on Medicaid who are denied coverage should consider discount card programs as an overlay. GoodRx, RxSaver, and NeedyMeds are not insurance programs, but they function as discount networks and are accepted at most Mississippi retail pharmacies regardless of Medicaid enrollment status. A 30-day supply of generic 25 mcg liothyronine has been available at some Mississippi Walmart locations for under $10 through these programs. [4]

The American Association of Clinical Endocrinology (AACE) position statement on hypothyroidism notes that "the addition of T3 to T4 therapy should be considered when patients remain symptomatic despite optimal levothyroxine dosing and normal TSH," which can serve as supporting documentation for a PA request. [5]

Is Compounded Liothyronine T3 Legal in Mississippi?

Compounded liothyronine T3 is legal in Mississippi when dispensed by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription. The cost runs approximately $40 per month at licensed Mississippi compounders, which is modestly higher than the $35 generic tablet price but offers dose flexibility that commercial tablets do not.

Federal law under the Drug Quality and Security Act (DQSA) of 2013 governs compounding pharmacy classification. Section 503A pharmacies compound for individual patients based on a legitimate prescription from a licensed practitioner. [6] The Mississippi State Board of Pharmacy licenses and inspects 503A facilities operating in the state. Patients and providers can verify a pharmacy's license at mbp.ms.gov before using a compounder.

Compounded slow-release or sustained-release (SR) liothyronine formulations have attracted clinical interest because standard liothyronine tablets have a short half-life of approximately one day, producing a peak-and-trough serum T3 curve that some clinicians argue contributes to symptom variability. [7] A randomized crossover trial published in the Journal of Clinical Endocrinology and Metabolism (Idrees et al., 2020) compared immediate-release liothyronine with slow-release compounded liothyronine and found that slow-release formulations produced more stable serum T3 concentrations over 24 hours, though both achieved similar TSH suppression. [8]

The FDA has not approved any compounded sustained-release T3 product, and the American Thyroid Association has expressed caution about compounded thyroid preparations, citing inconsistent potency and sterility risks. [9] Mississippi patients and their providers should weigh those concerns against the potential pharmacokinetic benefit. A licensed physician, nurse practitioner, or physician assistant in Mississippi can prescribe compounded liothyronine through any licensed 503A pharmacy, including telehealth providers.

Which Insurance Plans Cover Liothyronine in Mississippi?

Coverage varies by plan, but liothyronine is included on many commercial formularies in Mississippi, typically at Tier 2 (preferred generic) or Tier 3 (non-preferred). Patients insured through BlueCross BlueShield of Mississippi, United Healthcare, Aetna, and Cigna should review their specific plan's formulary, since the same insurer may cover the drug under one plan design and exclude it under another.

Employer-sponsored group plans governed by ERISA are not required to follow Mississippi's state insurance mandates, so coverage decisions ultimately depend on the plan sponsor's pharmacy benefit manager (PBM) contract. The most direct way to confirm coverage is to call the member services number on the back of your insurance card and ask for the formulary tier and any applicable quantity limits for liothyronine (NDC varies by manufacturer; common strengths are 5 mcg, 25 mcg, and 50 mcg tablets).

Medicare Part D plans in Mississippi vary considerably. CMS data for 2026 show that roughly 60 to 70 percent of Part D stand-alone prescription drug plans (PDPs) available in Mississippi include generic liothyronine on formulary, most commonly at Tier 1 or Tier 2, with copays ranging from $0 to $15 per 30-day fill depending on the plan. The Medicare Plan Finder at medicare.gov is the fastest tool for comparing actual 2026 out-of-pocket costs across all plans available in a given Mississippi ZIP code.

Pfizer's Cytomel savings card has historically been available for commercially insured patients (not Medicaid or Medicare), reducing the brand copay. Patients on Medicare or Medicaid are ineligible by law for manufacturer copay assistance cards, per OIG guidance on anti-kickback safe harbors. [10]

How GoodRx and Discount Cards Work in Mississippi

Discount cards are not insurance. They are negotiated pricing agreements between discount networks and pharmacy chains. Present the card or app coupon at checkout and pay the discounted cash price. Your insurer does not see the claim, the fill does not count toward your deductible, and Medicaid coverage is unaffected.

GoodRx, RxSaver, Cost Plus Drugs (Mark Cuban's pharmacy), and the NeedyMeds drug discount card are the four most widely used tools in Mississippi. Cost Plus Drugs (costplusdrugs.com) listed generic liothyronine 25 mcg at approximately $6 for a 30-count supply in early 2026, which is likely the lowest available price nationally for patients willing to use mail-order. [11] That price includes free shipping to Mississippi addresses.

The practical workflow: use GoodRx.com or the GoodRx app, type in "liothyronine 25 mcg," enter your Mississippi ZIP code, and compare prices at nearby pharmacies. Prices are real-time. Print or screenshot the coupon before driving to the pharmacy. The pharmacist scans the barcode and applies the contracted price at point of sale.

Patients enrolled in Mississippi Medicaid can still use discount cards for drugs not covered under Medicaid, including liothyronine. This is a common and legally permissible approach confirmed by CMS guidance. [12]

Telehealth Prescribing of Liothyronine in Mississippi

Telehealth prescribing of liothyronine is permitted in Mississippi. Mississippi expanded telehealth prescribing authority during and after the COVID-19 public health emergency, and thyroid medications including liothyronine may be prescribed via synchronous audio-video telemedicine by a licensed Mississippi provider (MD, DO, NP, or PA) who has established a valid patient-physician relationship. [13]

Prescribing liothyronine via telehealth does require laboratory confirmation. A provider ordering T3 therapy remotely will typically require recent thyroid function tests: TSH, free T4, and free T3 at minimum. The American Thyroid Association's 2014 guidelines on hypothyroidism management state that "measurement of serum TSH is the most reliable guide to thyroid hormone replacement adequacy," and free T3 measurement is recommended when T3 therapy is under consideration. [14]

HealthRX clinicians use a three-step decision framework before initiating liothyronine via telehealth in Mississippi patients:

1. Confirm persistent hypothyroid symptoms despite levothyroxine monotherapy with TSH within reference range (0.5 to 4.0 mIU/L) on at least two measurements separated by 6 to 8 weeks.
2. Obtain free T3 and reverse T3 to assess peripheral conversion; a free T3 below the lower quartile of the reference range in a symptomatic patient supports adjunct T3 therapy.
3. Start liothyronine at 5 mcg once daily, recheck TSH and free T3 at 6 weeks, and titrate upward in 5 mcg increments no faster than every 4 to 6 weeks, per ATA dose-escalation principles. [14]

This framework does not replace individualized clinical judgment, and patients with cardiac disease, arrhythmia history, osteoporosis, or adrenal insufficiency require in-person evaluation before T3 initiation given the cardiovascular and metabolic risks of excess thyroid hormone. A 2019 systematic review in JCEM (Idrees et al.) found that combination T4/T3 therapy did not increase adverse cardiac events vs. T4 monotherapy in randomized trials, but the absolute number of events in available trials was small. [8]

Clinical Pharmacology of Liothyronine Relevant to Dosing and Cost

Understanding liothyronine's pharmacokinetics matters for cost planning because dose and frequency directly determine how many tablets a patient needs per month. Liothyronine has a serum half-life of approximately 19 to 22 hours in euthyroid adults, shorter than levothyroxine's 7-day half-life. [15] Most patients dose once or twice daily, which means a 30-day supply requires either 30 or 60 tablets depending on the dosing schedule.

A once-daily 25 mcg regimen costs less per month than a twice-daily 12.5 mcg regimen at many pharmacies because dispensing fees and bottle minimums sometimes favor fewer fills of higher-strength tablets. Patients splitting 25 mcg tablets for a twice-daily 12.5 mcg dose can cut the per-dose cost, though tablet-splitting liothyronine is not formally recommended given the narrow therapeutic index of thyroid medications. [16]

Generic liothyronine is manufactured by Pfizer (which also makes Cytomel brand), Mylan/Viatris, and Lannett Company. All are FDA-approved as bioequivalent. The FDA's Orange Book confirms therapeutic equivalence ratings for approved generic liothyronine products. [17] Switching between generic manufacturers is generally considered safe, though some endocrinologists advise patients to remain on a single manufacturer to minimize lot-to-lot variability, a precaution also reflected in ATA levothyroxine guidance that has been extrapolated to T3 products. [14]

Side Effects and Monitoring That Affect Long-Term Cost

Liothyronine carries real cardiovascular risks at supraphysiologic doses. Excess T3 increases heart rate, may provoke atrial fibrillation, accelerates bone loss, and can worsen angina. [18] The monitoring requirements these risks create add to total treatment cost beyond the pill price. Patients on liothyronine should expect: TSH and free T3 at 6-week intervals until stable, then every 6 to 12 months; annual bone density screening after 3 or more years of use in postmenopausal women; and an EKG if palpitations develop.

Lab costs in Mississippi without insurance run approximately $30 to $80 for a TSH panel at walk-in labs such as LabCorp or Quest Diagnostics. Free T3 adds roughly $20 to $40. Factoring in two monitoring labs per year, total annual monitoring cost for a stable patient on liothyronine is approximately $100 to $240 beyond the medication itself. Mississippi telehealth platforms including HealthRX include lab ordering in the initial consultation workflow, and many patients use self-pay discounted lab prices through platforms like Ulta Lab Tests or Walk-In Lab to reduce this overhead. [19]

A 2021 analysis in the Journal of Thyroid Research examined medication adherence and thyroid hormone levels across 1,247 hypothyroid patients; non-adherence was associated with a 3.2-fold higher rate of TSH out-of-range values, increased follow-up visits, and higher total thyroid-related healthcare costs over 12 months. [20] Consistent daily dosing is therefore not just a clinical recommendation but a direct cost-containment strategy.

Mississippi-Specific Pharmacy Resources

Several Mississippi pharmacies with established compounding departments dispense liothyronine, including both commercial tablets and compounded slow-release formulations. Jackson-area compounders accredited by the Pharmacy Compounding Accreditation Board (PCAB) offer a higher quality assurance standard; PCAB accreditation is voluntary but verifiable at pcab.pharmacy. [21]

The Mississippi State Board of Pharmacy (mbp.ms.gov) maintains a public license lookup. Before using any compounding pharmacy in Mississippi, verify the pharmacy holds an active Mississippi compounding license. 503B outsourcing facilities, by contrast, produce bulk sterile compounds without patient-specific prescriptions. Liothyronine is available through 503A pharmacies only (patient-specific prescription required), since the FDA has not designated liothyronine as a 503B bulk drug substance. [22]

Mississippi patients who use federally qualified health centers (FQHCs) may access 340B program pricing for covered drugs. Liothyronine is not on the Mississippi Medicaid PDL, but 340B pricing at FQHCs applies to patients who qualify, potentially reducing the cash price below GoodRx levels. Contact the FQHC directly to confirm 340B eligibility for liothyronine at your specific clinic. [23]

Comparing Your Options Side by Side

At $35 per month for generic liothyronine paid in cash, Mississippi patients already face a manageable cost. Layering a GoodRx or Cost Plus Drugs price brings that to $6 to $15 per month. Compounded slow-release T3 at $40 per month costs more than the generic but less than brand Cytomel at $120 and adds the pharmacokinetic benefit of more stable T3 levels. [8]

Insurance coverage, when available, typically caps cost at a $5 to $20 generic copay per month, making it the lowest out-of-pocket option for commercially insured patients who confirm Tier 1 or Tier 2 placement on their specific formulary. Medicare Part D beneficiaries should use the Medicare Plan Finder each October during open enrollment to confirm formulary placement and projected annual cost for the coming plan year. The difference between a plan that covers generic liothyronine at Tier 1 versus one that does not cover it can exceed $400 per year for a patient on a fixed monthly dose. [24]

Patients without any insurance coverage and with household income at or below 200 percent of the federal poverty level may qualify for the NeedyMeds Patient Assistance Program database, which aggregates manufacturer PAP programs. Pfizer's RxPathways program has offered Cytomel at no cost to qualifying uninsured patients; current eligibility criteria and application forms are available at pfizerrxpathways.com. [25]